Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study.

Pode-Shakked B, Shemer-Meiri L, Harmelin A, Stettner N, Brenner O, Abraham S, Schwartz G, Anikster Y.

Mol Genet Metab. 2013;110 Suppl:S66-70. doi: 10.1016/j.ymgme.2013.10.006. Epub 2013 Oct 12.

PMID:
24206931
2.

Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.

Fattal-Valevski A, Kesler A, Sela BA, Nitzan-Kaluski D, Rotstein M, Mesterman R, Toledano-Alhadef H, Stolovitch C, Hoffmann C, Globus O, Eshel G.

Pediatrics. 2005 Feb;115(2):e233-8.

PMID:
15687431
3.

[Clinical studies of pediatric malabsorption syndromes].

Hosoyamada T.

Fukuoka Igaku Zasshi. 2006 Nov;97(11):322-50. Japanese.

PMID:
17228786
4.
6.

Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.

Martynyuk AE, Ucar DA, Yang DD, Norman WM, Carney PR, Dennis DM, Laipis PJ.

Epilepsia. 2007 Jun;48(6):1143-50. Epub 2007 May 1.

7.

[Serum tyrosine in children with phenylketonuria and mild hyperphenylalaninemia].

Cabalska B, Nowacka M, Laskowska-Klita T, Nowaczewska I, Zorska K, TaljaĊ„ski W.

Med Wieku Rozwoj. 2000 Jan-Mar;4(1):5-12. Polish.

PMID:
11013857
8.

Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.

Yannicelli S, Medeiros DM.

J Inherit Metab Dis. 2002 Sep;25(5):347-61.

PMID:
12408184
9.
10.

Breast-feeding in the management of the newborn with phenylketonuria: a practical approach to dietary therapy.

Greve LC, Wheeler MD, Green-Burgeson DK, Zorn EM.

J Am Diet Assoc. 1994 Mar;94(3):305-9. Erratum in: J Am Diet Assoc 1994 Jul;94(7):716.

PMID:
8120296
11.

Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy.

Acosta PB, Yannicelli S, Singh R, Mofidi S, Steiner R, DeVincentis E, Jurecki E, Bernstein L, Gleason S, Chetty M, Rouse B.

J Am Diet Assoc. 2003 Sep;103(9):1167-73.

PMID:
12963945
12.

Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/postprandial) in patients with phenylketonuria: effect of sample timing.

van Spronsen FJ, van Rijn M, van Dijk T, Smit GP, Reijngoud DJ, Berger R, Heymans HS.

Pediatrics. 1993 Oct;92(4):570-3.

PMID:
8414829
13.

Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Sawin EA, Murali SG, Ney DM.

Mol Genet Metab. 2014 Apr;111(4):452-61. doi: 10.1016/j.ymgme.2014.01.015. Epub 2014 Feb 8.

14.

Tyrosine supplementation for phenylketonuria.

Webster D, Wildgoose J.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD001507. doi: 10.1002/14651858.CD001507.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD001507.

PMID:
20687067
15.
16.

Treatment of phenylketonuria during pregnancy.

Michels VV, Justice CL.

Clin Genet. 1982 Feb;21(2):141-4.

PMID:
7083615
17.
18.

Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.

Dobbelaere D, Michaud L, Debrabander A, Vanderbecken S, Gottrand F, Turck D, Farriaux JP.

J Inherit Metab Dis. 2003;26(1):1-11.

PMID:
12872834
19.

Vitamin B12 deficiency in adolescents and young adults with phenylketonuria.

Hanley WB, Feigenbaum AS, Clarke JT, Schoonheyt WE, Austin VJ.

Eur J Pediatr. 1996 Jul;155 Suppl 1:S145-7.

PMID:
8828632
20.

Supplemental Content

Support Center